Sanofi, Breakthrough T1D UK, and Beano have partnered to create a bespoke comic strip to raise awareness of autoimmune Type 1 ...

Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.

Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...

Crypto platform DeFi Technologies has created a new company called SolFi designed to be a "Microstrategy for Solana" with ...

As you can see, Sanofi's strong global presence and proven track record in developing and commercializing vaccines, combined ...

The drugmaker has won an appeal against NICE's recent final draft guidance on Sarclisa (isatuximab) as a regimen alongside ...

Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab, AstraZeneca’s benralizumab, Amgen Inc ...

Access to innovation is proving increasingly difficult for UK cancer patients. Unpicking the policy barriers is important for ...

On the first day at the rare-diseases-focused event, Vinciane Pirard, Scientific Advocacy and Insights, Medical Affairs Rare ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to ...

Former pro athletes Sebastien and Caroline Graeff transform the supplement industry with Naiad, a wellness brand merging ...